Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Change in Cash (2018 - 2025)

Historic Change in Cash for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to -$222415.0.

  • Abvc Biopharma's Change in Cash fell 92059.84% to -$222415.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $84038.0, marking a year-over-year increase of 12393.81%. This contributed to the annual value of $147035.0 for FY2024, which is 12178.46% up from last year.
  • According to the latest figures from Q3 2025, Abvc Biopharma's Change in Cash is -$222415.0, which was down 92059.84% from $316758.0 recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Change in Cash registered a high of $2.8 million during Q3 2021, and its lowest value of -$3.1 million during Q1 2022.
  • Over the past 5 years, Abvc Biopharma's median Change in Cash value was -$57778.0 (recorded in 2024), while the average stood at -$218287.4.
  • Within the past 5 years, the most significant YoY rise in Abvc Biopharma's Change in Cash was 119728.58% (2021), while the steepest drop was 797813.56% (2021).
  • Quarter analysis of 5 years shows Abvc Biopharma's Change in Cash stood at $2.1 million in 2021, then plummeted by 127.34% to -$578419.0 in 2022, then soared by 30.13% to -$404157.0 in 2023, then surged by 123.24% to $93942.0 in 2024, then crashed by 336.76% to -$222415.0 in 2025.
  • Its last three reported values are -$222415.0 in Q3 2025, $316758.0 for Q2 2025, and -$104247.0 during Q1 2025.